Relay Therapeutics(RLAY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RLAY Relay Therapeutics

交易中 06-10 11:17:51 EDT

13.90

-0.19

-1.38%

最高14.58	最低13.89	成交量46.60万
今开13.99	昨收14.09	日振幅4.91%
总市值29.87亿	流通市值20.98亿	总股本2.15亿
成交额665.20万	换手率0.31%	流通股本1.51亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RLAY","market":"US","secType":"STK","nameCN":"Relay Therapeutics","latestPrice":13.895,"timestamp":1781104670335,"preClose":14.09,"halted":0,"volume":466002,"delay":0,"changeRate":-0.013839602555003569,"floatShares":151000000,"shares":215000000,"eps":-1.565106,"marketStatus":"交易中","change":-0.195,"latestTime":"06-10 11:17:51 EDT","open":13.99,"high":14.58,"low":13.8877,"amount":6651953.937036,"amplitude":0.049134,"askPrice":13.89,"askSize":11,"bidPrice":13.87,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-1.565106,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781121600000},"marketStatusCode":2,"adr":0,"listingDate":1594872000000,"exchange":"NASDAQ","adjPreClose":14.09,"preHourTrading":{"tag":"盘前","latestPrice":13.81,"preClose":14.09,"latestTime":"09:27 EDT","volume":329,"amount":4555.007632,"timestamp":1781098050050,"change":-0.28,"changeRate":-0.019872,"amplitude":0.007807},"postHourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":14.09,"latestTime":"18:58 EDT","volume":53963,"amount":759152.62,"timestamp":1781045880655,"change":-0.28,"changeRate":-0.019872,"amplitude":0.053229},"volumeRatio":0.391888,"impliedVol":0.9684,"impliedVolPercentile":0.5139},"requestUrl":"/m/hq/s/RLAY","defaultTab":"news","newsList":[{"id":"1106856404","title":"Relay Therapeutics股价盘前大涨7.5%，其药物在中期试验中成功缩小血管畸形","url":"https://stock-news.laohu8.com/highlight/detail?id=1106856404","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106856404?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:34","pubTimestamp":1779186854,"startTime":"0","endTime":"0","summary":"Relay Therapeutics的股价在盘前交易时段飙升7.5%，此前该公司宣布其研发的药物在一项中期临床试验中成功使患者的血管畸形缩小。这一积极数据极大地提振了投资者信心，市场对这款创新疗法的前景抱有更高期待。血管畸形领域的治疗需求长期未被满足，此次试验结果被视为该药物开发路径上的一个重要里程碑，可能为后续更大规模的临床研究铺平道路。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160613554","title":"Relay Therapeutics：第12周临床改善率达89%（研究者报告）与79%（患者报告）","url":"https://stock-news.laohu8.com/highlight/detail?id=1160613554","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160613554?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:05","pubTimestamp":1779185109,"startTime":"0","endTime":"0","summary":"Relay Therapeutics公司公布的最新数据显示，在第12周的治疗评估中，根据研究者的报告，临床改善率达到89%；而根据患者自身的报告，改善率也达到了79%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RLAY","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183277955","title":"Relay Therapeutics：截至2026年4月15日，60%患者在12周时实现体积缓解","url":"https://stock-news.laohu8.com/highlight/detail?id=1183277955","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183277955?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:03","pubTimestamp":1779185009,"startTime":"0","endTime":"0","summary":"Relay Therapeutics公司公布的最新数据显示，截至2026年4月15日，其临床研究中已有60%的患者在治疗12周后达到体积缓解标准。这一阶段性成果标志着该疗法在特定患者群体中展现出显著的治疗潜力，为后续临床开发提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152865937","title":"Relay Therapeutics公布初步临床数据，显示Zovegalisib在治疗Pik3CA驱动血管异常患者中具备差异化安全性与疗效潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1152865937","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152865937?lang=zh_cn&edition=full","pubTime":"2026-05-19 18:02","pubTimestamp":1779184922,"startTime":"0","endTime":"0","summary":"Relay Therapeutics公司发布了其药物Zovegalisib的初步临床数据，表明该药物在针对由Pik3CA基因驱动的血管异常患者群体中，展现出具有差异化优势的安全性和疗效前景。这些早期数据提示，Zovegalisib可能为该患者群体提供一种新的潜在治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RLAY","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197738020","title":"Relay Therapeutics公布晚期CDK4/6经治乳腺癌患者客观缓解率达44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197738020","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197738020?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:01","pubTimestamp":1777284081,"startTime":"0","endTime":"0","summary":"生物技术公司Relay Therapeutics近日披露其创新疗法在经多线治疗的CDK4/6抑制剂经治乳腺癌患者群体中取得突破性数据。临床研究显示，针对这类预后极差的晚期患者，实验性治疗方案实现了44%的客观缓解率，为现有治疗选择有限的人群带来新的希望。所有入组患者均曾使用CDK4/6抑制剂但出现疾病进展，属于临床治疗中的难点人群。研究人员指出，这一结果验证了公司专有蛋白质运动学平台在药物发现中的价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139233400","title":"Relay Therapeutics公布Zovegalisib联合阿替莫西布三联疗法临床数据 支持晚期转移性乳腺癌一线治疗进一步开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1139233400","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139233400?lang=zh_cn&edition=full","pubTime":"2026-04-27 18:01","pubTimestamp":1777284080,"startTime":"0","endTime":"0","summary":"生物医药公司Relay Therapeutics近日公布了其创新药物Zovegalisib与阿替莫西布组成的三联疗法临床研究数据。该数据表明，这一组合方案在晚期转移性乳腺癌的一线治疗中展现出令人鼓舞的潜力，为后续临床开发提供了有力支持。此次公布的临床结果凸显了三联疗法在应对转移性乳腺癌方面的治疗价值。这一进展标志着Relay Therapeutics在肿瘤治疗领域的重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617575662","title":"Relay Therapeutics, Inc.2025财年实现净利润-2.76亿美元，同比增加18.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617575662","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617575662?lang=zh_cn&edition=full","pubTime":"2026-03-08 00:00","pubTimestamp":1772899221,"startTime":"0","endTime":"0","summary":"3月8日，Relay Therapeutics, Inc.公布财报，公告显示公司2025财年净利润为-2.76亿美元，同比增加18.34%；其中营业收入为15.36百万美元，同比增加53.45%，每股基本收益为-1.61美元。从资产负债表来看，Relay Therapeutics, Inc.总负债54.27百万美元，其中短期债务3.77百万美元，资产负债比为0.12，流动比率为0.23。机构评级：截至2026年3月8日，当前有10家机构对Relay Therapeutics, Inc.目标价做出预测，其中目标均价为15.80美元，其中最低目标价为13.00美元，最高目标价为19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308000023a4568cce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260308000023a4568cce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611233906","title":"Relay Therapeutics, Inc.盘中异动 早盘股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611233906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611233906?lang=zh_cn&edition=full","pubTime":"2026-02-13 00:00","pubTimestamp":1770912040,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日00时00分，Relay Therapeutics, Inc.股票出现异动，股价急速下跌5.14%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213000041a6f409cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213000041a6f409cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4563","RLAY","LENZ","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610017956","title":"Relay Therapeutics, Inc.盘中异动 早盘股价大跌5.01%报8.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610017956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610017956?lang=zh_cn&edition=full","pubTime":"2026-02-11 22:51","pubTimestamp":1770821468,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日22时51分，Relay Therapeutics, Inc.股票出现波动，股价急速下跌5.01%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122510897a5d2d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021122510897a5d2d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4563","BK4007","BK4139","RLAY","BK4539","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518746142","title":"Relay Therapeutics, Inc.盘中异动 股价大跌5.06%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518746142","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518746142?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:30","pubTimestamp":1741617018,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时30分，Relay Therapeutics, Inc.股票出现异动，股价大幅下挫5.06%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223019a26a3b4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223019a26a3b4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLAY","BK4563","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517351924","title":"Relay Therapeutics, Inc.盘中异动 临近收盘急速上涨6.27%报3.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517351924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517351924?lang=zh_cn&edition=full","pubTime":"2025-03-06 05:00","pubTimestamp":1741208405,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日05时00分，Relay Therapeutics, Inc.股票出现异动，股价大幅拉升6.27%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.91%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050005963b2fca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306050005963b2fca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4563","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516677175","title":"Relay Therapeutics, Inc.盘中异动 急速下挫5.00%报3.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677175?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:51","pubTimestamp":1741099861,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时51分，Relay Therapeutics, Inc.股票出现异动，股价急速下挫5.00%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422510196394ad1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422510196394ad1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLAY","BK4563","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516637686","title":"Relay Therapeutics, Inc.盘中异动 快速拉升5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637686?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:33","pubTimestamp":1741012400,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时33分，Relay Therapeutics, Inc.股票出现异动，股价大幅上涨5.28%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223320abe633ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223320abe633ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RLAY","BK4563","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516548049","title":"Relay Therapeutics, Inc.2024财年实现净利润-3.38亿美元，同比增加1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516548049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516548049?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931290,"startTime":"0","endTime":"0","summary":"3月3日，Relay Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-3.38亿美元，同比增加1.17%；其中营业收入为10.01百万美元，同比减少60.82%，每股基本收益为-2.36美元。从资产负债表来看，Relay Therapeutics, Inc.总负债93.50百万美元，其中短期债务5.73百万美元，资产负债比为0.10，流动比率为0.16。机构评级：截至2025年3月3日，当前有11家机构对Relay Therapeutics, Inc.目标价做出预测，其中目标均价为19.64美元，其中最低目标价为12.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000227a25bbca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000227a25bbca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514378392","title":"Relay Therapeutics, Inc.盘中异动 急速下挫5.08%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378392?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:39","pubTimestamp":1740753596,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时39分，Relay Therapeutics, Inc.股票出现波动，股价大幅下挫5.08%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822395696341b94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022822395696341b94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4563","BK4139","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514038599","title":"Relay Therapeutics, Inc.盘中异动 股价大跌8.00%报3.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514038599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514038599?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:30","pubTimestamp":1740666624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时30分，Relay Therapeutics, Inc.股票出现波动，股价快速下挫8.00%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722302498950fb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RLAY","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170085581","title":"Relay Therapeutics 第四季度 GAAP 每股收益 (EPS) 为 $(0.45)，好于预期的 $(0.58)","url":"https://stock-news.laohu8.com/highlight/detail?id=1170085581","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170085581?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:34","pubTimestamp":1740605676,"startTime":"0","endTime":"0","summary":"Relay Therapeutics报告其季度每股亏损为 $，比分析师一致预期的 $ 高出 22.41%。与去年同期每股亏损 $ 相比，增幅为 32.84%。以上内容来自Benzinga Earnings专栏，原文如下：$Relay Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 22.41 percent. This is a 32.84 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Relay Therapeutics 第四季度 GAAP 每股收益 (EPS) 为 $(0.45)，好于预期的 $(0.58)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086396","title":"Relay Therapeutics, Inc.盘中异动 股价大涨5.03%报3.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514086396?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:16","pubTimestamp":1740590195,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时16分，Relay Therapeutics, Inc.股票出现波动，股价快速上涨5.03%。截至发稿，该股报3.87美元/股，成交量44.0652万股，换手率0.26%，振幅4.89%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011636a2551cdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011636a2551cdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4563","RLAY","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514190010","title":"Relay Therapeutics, Inc.盘中异动 股价大跌5.03%报3.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514190010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514190010?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:17","pubTimestamp":1740500225,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时17分，Relay Therapeutics, Inc.股票出现波动，股价急速跳水5.03%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001705963009a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001705963009a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4563","RLAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775880","title":"Relay Therapeutics, Inc.盘中异动 急速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775880","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775880?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:46","pubTimestamp":1740412007,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时46分，Relay Therapeutics, Inc.股票出现波动，股价大幅下挫5.10%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234647962eaa6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234647962eaa6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RLAY","LENZ","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.relaytx.com","stockEarnings":[{"period":"1week","weight":-0.1025},{"period":"1month","weight":0.1042},{"period":"3month","weight":0.3046},{"period":"6month","weight":0.8087},{"period":"1year","weight":3.1935},{"period":"ytd","weight":0.6655}],"compareEarnings":[{"period":"1week","weight":-0.0296},{"period":"1month","weight":-0.0008},{"period":"3month","weight":0.0898},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.2291},{"period":"ytd","weight":0.0808}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Relay Therapeutics, Inc.于2015年5月4日在特拉华州注册成立。该公司是一家临床阶段的精密药物公司，致力于转变药物发现过程，最初的重点是增强靶向肿瘤学中的小分子治疗发现。该公司建立在对蛋白质运动以及这种动态行为与蛋白质功能之间无与伦比的洞察力之上。该公司的Dynamo平台集成了一系列先进的实验和计算方法，使该公司可以将对蛋白质结构和运动的理解应用于药物开发。该公司正在开发其主要候选产品RLY-4008和RLY-1971，并为PI3Kα选择性突变体计划（RLY-PI3K1047计划）开发候选药物，以治疗晚期实体瘤患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.030089},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02334},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.05578},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.039525},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.059332},{"month":6,"riseRate":1,"avgChangeRate":0.078141},{"month":7,"riseRate":0.8,"avgChangeRate":0.060673},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002424},{"month":9,"riseRate":0.5,"avgChangeRate":0.056272},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.022719},{"month":11,"riseRate":0.5,"avgChangeRate":0.050992},{"month":12,"riseRate":0.5,"avgChangeRate":-0.005964}],"exchange":"NASDAQ","name":"Relay Therapeutics","nameEN":"Relay Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Relay Therapeutics(RLAY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Relay Therapeutics(RLAY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Relay Therapeutics,RLAY,Relay Therapeutics股票,Relay Therapeutics股票老虎,Relay Therapeutics股票老虎国际,Relay Therapeutics行情,Relay Therapeutics股票行情,Relay Therapeutics股价,Relay Therapeutics股市,Relay Therapeutics股票价格,Relay Therapeutics股票交易,Relay Therapeutics股票购买,Relay Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Relay Therapeutics(RLAY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Relay Therapeutics(RLAY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}